-
VNDA Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Vanda Pharmaceuticals (VNDA)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 100.97 mm | 100.97 mm | 100.97 mm | 100.97 mm | 100.97 mm | 100.97 mm |
Cash burn (monthly) | 818.67 k | 6.89 mm | 3.67 mm | 3.12 mm | 4.86 mm | 1.47 mm |
Cash used (since last report) | 3.29 mm | 27.72 mm | 14.75 mm | 12.56 mm | 19.55 mm | 5.92 mm |
Cash remaining | 97.67 mm | 73.25 mm | 86.22 mm | 88.41 mm | 81.42 mm | 95.04 mm |
Runway (months of cash) | 119.3 | 10.6 | 23.5 | 28.3 | 16.8 | 64.5 |
13F holders | Current |
---|---|
Total holders | 151 |
Opened positions | 25 |
Closed positions | 25 |
Increased positions | 46 |
Reduced positions | 52 |
13F shares | Current |
---|---|
Total value | 192.51 bn |
Total shares | 43.87 mm |
Total puts | 33.60 k |
Total calls | 165.40 k |
Total put/call ratio | 0.2 |
Largest owners | Shares | Value |
---|---|---|
BlackRock | 8.60 mm | $40.31 bn |
Renaissance Technologies | 4.01 mm | $18.81 bn |
Vanguard | 3.63 mm | $17.03 bn |
Tang Capital Management | 2.35 mm | $11.04 bn |
Dimensional Fund Advisors | 2.26 mm | $10.60 bn |
Acadian Asset Management | 1.90 mm | $8.91 mm |
Nantahala Capital Management | 1.59 mm | $7.47 bn |
Jacobs Levy Equity Management | 1.43 mm | $6.71 bn |
Geode Capital Management | 1.43 mm | $6.69 bn |
STT State Street | 1.17 mm | $5.46 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
14 Nov 24 | Mitchell Stephen Ray | Common Stock | Sell | Dispose S | No | No | 5.1726 | 5,000 | 25.86 k | 44,857 |
29 Jul 24 | Kevin Patrick Moran | Common Stock | Sell | Dispose S | No | No | 5.9203 | 2,251 | 13.33 k | 228,763 |
22 May 24 | Chrousos Phaedra | Common Stock | Grant | Acquire A | No | No | 0 | 21,887 | 0.00 | 64,125 |
22 May 24 | Chrousos Phaedra | Stock Option Common Stock | Grant | Acquire A | No | No | 5.14 | 40,202 | 206.64 k | 40,202 |
17 May 24 | Tage Honore | Common Stock | Grant | Acquire A | No | No | 0 | 20,529 | 0.00 | 64,244 |
17 May 24 | Tage Honore | Stock Option Common Stock | Grant | Acquire A | No | No | 5.48 | 37,578 | 205.93 k | 37,578 |
17 May 24 | Ward Anne Sempowski | Common Stock | Grant | Acquire A | No | No | 0 | 20,529 | 0.00 | 59,842 |
17 May 24 | Ward Anne Sempowski | Stock Option Common Stock | Grant | Acquire A | No | No | 5.48 | 37,578 | 205.93 k | 37,578 |